Are neurobiological features defining subtypes of brain dysfunction in major depressive disorder trait or state? Characterizing the determinants of familial risk and treatment remission in neurobiologically-derived subtypes of major depressive disorder.

神经生物学特征是否定义了重度抑郁症特征或状态中脑功能障碍的亚型？

• 批准号: 373784
• 负责人: Dunlop Katharine A
• 金额: $ 10.2万
• 依托单位: Weill Cornell Medical College (New York, NY)
• 依托单位国家: 加拿大
• 项目类别: Fellowship Programs
• 财政年份: 2017
• 资助国家: 加拿大
• 起止时间: 2017-09-01 至 2019-09-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=373784&lang=en
• 关键词: Biomarker Research; Classification - Disorder Subtypes; Depression; Fmri; Mri

13-16% of Canadians will develop an episode of major depressive disorder (MDD), and conventional treatments have low recovery rates. One of the most significant barriers to improving these rates is that we lack a robust understanding of the differences be

13-16%的加拿大人会发展为重度抑郁症（MDD），而传统治疗的恢复率很低。提高这些比率的最大障碍之一是，我们对它们之间的差异缺乏强有力的了解